Schowinsky ALL and AML Flashcards

1
Q

What are acute leukemias

A

clonal neoplastic hematopoietic cells, usually immature, presenting as a rapidly progessing disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

define AML

A

leukemic cells resembling cells of myeloid lineages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

define ALL

A

leukemic cells resembling precursor lymphocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

risk factors for acute leukemia

A

previous chemotherapy, exposure of active marrow to ionizing radiation, tobacco smoke, benzene exposure, and genetic syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

T or F: the majority of acute leukemias occur in the apparent absence of risk factors

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

T or F: Presenting signs and symptoms usually result from replacement of normal marrow cells by leukemic cells.

A

True: can exhibit S/sx of anemia, thrombocytopenia, and neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

T or F: Thrombotic events, DIC, and direct infiltration of skin, gums, and lymph nodes are very common presenting signs and symptoms of acute leukemias

A

False: these do occur, but more rarely

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

T or F: neoplams of precursor lymphoid cells manifest as AML, and commonly have a solid mass (lymphoblastic lymphoma)

A

False: manifest as ALL, and solid masses are less common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

T or F: 75% of cases of ALL occur in children less than 6 yrs old

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

name 3 factors to notice when diagnosing ALL

A

1) nearly always see “packed marrow” full of blast cells. 2) peripheral WBC count can vary greatly (high, normal, or low) 3) determine the blast type by immunophenotyping

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the basic marker of immaturity

A

CD34

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

common lymphoblast marker

A

TdT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

basic markers for precursor-B cells

A

CD19, CD22

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

basic markers for precursor-T cells

A

CD3, CD7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

T or F: B-ALL accounts for 80-85% of cases of ALL

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

T or F: B-ALL usually lacks mature B cell markers like CD20 and surface immunoglobulin

A

TRUE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

T or F: B-ALL is the typical ALL of adulthood

A

FALSE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does t(9:22) indicate

A

“Ph+ ALL”. B-ALL with Philadelphia chromosome, produces a fusion protein of BCR-ABL. Seen in 25% of adult ALL and 2% of childhood ALL. WORST PROGNOSIS OF ANY SUBTYPE ALL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What does translocation 11q23 indicate

A

“MLL” B-ALL more frequently seen in neonates and young infants. Has a poor prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What does t(12:21) indicate

A

“ETV6-RUNX1” 25% of cases of childhood B-ALL. Very favorable prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

T or F: T-ALL accounts for around 25% of cases of ALL

A

TRUE

22
Q

T or F: At least 105% of ALL cases are B-ALL and T-ALL

A

FACT!!! 80% B-ALL + 25% T-ALL = 105 fucking %! Where are your gods now?!

23
Q

T or F: T-ALL is less frequent in adolescents and young adults.

A

FALSE

24
Q

T or F: T-ALL often presents with a T-lymphoblastic lymphoma.

A

TRUE: T-LBL can often present as a mediastinal mass

25
Q

What can you say about T-ALL when it comes to WBC and sex?

A

markedly elevated WBC count compared to B-ALL, favors males over females

26
Q

T or F: In general, ALL has a “good prognosis” in children and a worse prognosis in adults

A

TRUE: complete remission rates are >95% vs 60-80% and cure rates are at 80% vs <50% in kids and adults respectively

27
Q

Give 2 factors of better prognosis in ALL with reference to age and disease

A

school age (2-10 yo), B-lymphoblastic hyperdiploidy (51-65)

28
Q

Give some factors of worse prognosis in ALL with reference to age and disease

A

Infants (10 yo), Very high WBC, T-lymphoblastic hypodiploidy (<46), slow response to Rx, Min. Residual disease

29
Q

T or F: AML is a more heterogeneous disease than ALL and is typically seen in adults

A

TRUE

30
Q

What is the big marker for diagnosing AML for most cases?

A

> 20% myeloblasts in the marrow and/or peripheral blood

31
Q

basic markers for the common myeloid lineage

A

CD117(C-kit) and myeloperoxidase

32
Q

What is one hystological feature that can help identify myeloblasts sometimes?

A

Auer rods

33
Q

T or F: some cytogenetic abnormalities allow for diagnosis of AML regardless of blast count

A

TRUE

34
Q

What does t(8:21) indicate

A

“RUNX1-RUNX1T1” 5% of AML cases, younger patients, “AML with maturation” some mature neutrophil production occurs, relatively good prognosis, diagnostic regardless of blast count

35
Q

What does inv(16) or t(16:16)

A

“CBFB-MYH11” 5-10% of AML cases, younger patients, “baso eso” abnormality, typically have myelomonocytic leukemia (myeloblasts and monocytes), relatively good prognosis

36
Q

What does t(15:17) indicate

A

“PML-RARA” acute promyelocytic leukemia (APL), also called M3-AML, hypergranular morphology resembling normal promyelocytes, may see multiple Auer rods, diagnostic of AML regardless of count. Good prognosis if caught early

37
Q

what does the RARA gene do?

A

it is a retinoic acid receptor. PML-RARA is a poorly functioning retinoic acid receptor. Proper function required for differentiation past promyelocyte stage

38
Q

How do we treat APL?

A

supraphysiologic doses of all-trans retinoic acid (ATRA), do not require traditional induction chemo. Can be treated with ATRA and arsenic salts (little morbidity and almost no mortality)

39
Q

What is something really bad that is associated with APL?

A

DIC

40
Q

what does t(1:22) indicate?

A

“RBM15-MKL1”, Megakaryoblastic differentiation, seen in infants with Down syndrome, relatively good prognosis

41
Q

What does 11q23 indicate?

A

“MLL” multiple possible partner genes, show some degree of monocytic differentiation, POOR prognosis

42
Q

Describe therapy related AML (t-AML)

A

AML arising secondary to DNA damage from a prior treatment, 10-20% of AML, VERY BAD PROGNOSIS

43
Q

AML, Not Otherwise Specified (NOS)

A

cases lacking recurrent cytogenetic findings, no known therapy, defined by morphology and immunophenotyping

44
Q

What subtype of AML NOS has myeloblast cells

A

Undifferentiated, minimally differentiated or with maturation

45
Q

What subtype of AML NOS has myeloblast and monocyte cells

A

Myelomonocytic

46
Q

What subtype of AML NOS has monoblast, promonocyte, and/or monocyte cells

A

monoblastic or monocytic

47
Q

What is seen with monoblastic or monocytic AML NOS

A

Leukemic cells often causes lesions in skin and gums

48
Q

What subtype of AML NOS has Megakaryoblasts cells

A

Megakaryoblastic

49
Q

What is seen with Megakaryoblastic AML NOS

A

often associated with significant marrow fibrosis

50
Q

What molecular abnormality has poor prognosis

A

FTL3 Internal Tandem Duplication (ITD)

51
Q

What 2 molecular abnormalities have a good prognosis

A

Nucleophosmin-1 mutation (NPM1) and CEBPA Mutation. This is assuming there is no FLT3 ITD

52
Q

T or F: patients that are healthy enough can have hematopoietic stem cell transplant (SCT).

A

TRUE: Therapy of choice for younger patients, high risk disease, and relapsed disease